Biostar Pharmaceuticals, Inc. (BSPM)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT
Biostar Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2007 - 2011 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '17 Sep 30, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2007 - 2011 |
Cash & Equivalents | 0.36 | 0.17 | 0.04 | 1.69 | 0.08 | 1.76 | Upgrade
|
Cash & Short-Term Investments | 0.36 | 0.17 | 0.04 | 1.69 | 0.08 | 1.76 | Upgrade
|
Cash Growth | -44.65% | 345.50% | -97.69% | 2004.55% | -95.45% | -89.63% | Upgrade
|
Accounts Receivable | - | 6.74 | 15.81 | 26.96 | 19.6 | 21.85 | Upgrade
|
Other Receivables | 0.46 | 0.28 | 0.08 | 0.12 | 2.22 | 4.36 | Upgrade
|
Receivables | 0.46 | 7.03 | 15.89 | 36.85 | 31.64 | 35.72 | Upgrade
|
Inventory | 0.17 | 0.17 | 0.23 | 0.67 | 0.83 | 0.85 | Upgrade
|
Prepaid Expenses | - | - | - | 0.35 | - | - | Upgrade
|
Other Current Assets | 0 | 0 | 0 | 4.07 | 3.44 | 3.65 | Upgrade
|
Total Current Assets | 1 | 7.37 | 16.17 | 43.63 | 35.99 | 41.97 | Upgrade
|
Property, Plant & Equipment | 5.85 | 5.87 | 6.81 | 8.48 | 7.73 | 6.98 | Upgrade
|
Other Intangible Assets | 5.38 | 5.61 | 6.88 | 13.27 | 17.13 | 9.14 | Upgrade
|
Long-Term Deferred Tax Assets | 2.63 | 2.52 | 5.41 | 7.07 | 2.79 | 3.67 | Upgrade
|
Other Long-Term Assets | 26.58 | 21.15 | 16.1 | 8.8 | 3.93 | 8.72 | Upgrade
|
Total Assets | 41.43 | 42.5 | 51.36 | 81.25 | 67.56 | 70.48 | Upgrade
|
Accounts Payable | 2.69 | 2.84 | 4.15 | 5 | 4.45 | 5.73 | Upgrade
|
Accrued Expenses | - | - | 0.11 | 0.43 | 0.34 | 0.63 | Upgrade
|
Short-Term Debt | 2.43 | 2.33 | 2.77 | 3.09 | - | 6.34 | Upgrade
|
Other Current Liabilities | 0.17 | 0.46 | 0.06 | 0.38 | - | - | Upgrade
|
Total Current Liabilities | 5.28 | 5.62 | 7.1 | 8.91 | 4.79 | 12.7 | Upgrade
|
Total Liabilities | 5.28 | 5.62 | 7.1 | 8.91 | 4.79 | 12.7 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 31.38 | 31.38 | 30.32 | 30.32 | 25.75 | 23.27 | Upgrade
|
Retained Earnings | 2.36 | 4.81 | 10.51 | 35.62 | 30.78 | 29.97 | Upgrade
|
Comprehensive Income & Other | 2.4 | 0.68 | 3.43 | 6.39 | 6.24 | 4.53 | Upgrade
|
Total Common Equity | 36.15 | 36.88 | 44.27 | 72.34 | 62.77 | 57.77 | Upgrade
|
Shareholders' Equity | 36.15 | 36.88 | 44.27 | 72.34 | 62.77 | 57.77 | Upgrade
|
Total Liabilities & Equity | 41.43 | 42.5 | 51.36 | 81.25 | 67.56 | 70.48 | Upgrade
|
Total Debt | 2.43 | 2.33 | 2.77 | 3.09 | - | 6.34 | Upgrade
|
Net Cash (Debt) | -2.06 | -2.15 | -2.73 | -1.41 | 0.08 | -4.58 | Upgrade
|
Net Cash Per Share | -0.79 | -0.94 | -1.24 | -0.68 | 0.05 | -3.35 | Upgrade
|
Filing Date Shares Outstanding | 2.64 | 2.64 | 2.21 | 2.21 | 1.81 | 1.43 | Upgrade
|
Total Common Shares Outstanding | 2.64 | 2.64 | 2.21 | 2.21 | 1.81 | 1.43 | Upgrade
|
Working Capital | -4.28 | 1.74 | 9.07 | 34.72 | 31.19 | 29.27 | Upgrade
|
Book Value Per Share | 13.71 | 13.98 | 20.02 | 32.72 | 34.66 | 40.47 | Upgrade
|
Tangible Book Value | 30.77 | 31.27 | 37.39 | 59.07 | 45.64 | 48.64 | Upgrade
|
Tangible Book Value Per Share | 11.67 | 11.86 | 16.91 | 26.72 | 25.20 | 34.07 | Upgrade
|
Buildings | 7.84 | 7.46 | 8.07 | 9.55 | 6.68 | 5.51 | Upgrade
|
Machinery | 1.31 | 1.25 | 1.35 | 1.41 | 1.41 | 1.36 | Upgrade
|
Construction In Progress | 0.47 | 0.45 | 0.48 | 0.52 | 2.15 | 2.08 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.